Nuvectis Pharma

NVCTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$617.420 M

$18.95 +0.64%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$26.4M

Loss-making

Shares outstanding

32,581,533

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#193Faeth TherapeuticsFTH$630.2M
#194Crescent BiopharmaCBIO$625.5M
#195Nuvectis PharmaNVCT$617.4M
#196ARS PharmaceuticalsSPRY$611.7M
#197AltimmuneALT$599.0M

Where these numbers come from

Share counts and financials for Nuvectis Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.